In this study, we hypothesized that the exposure of immune cells from MS patients to the SARS-CoV-2 S protein and LPS would trigger an inflammatory response characterized by elevated cytokine levels, and that this response could be regulated by the presence of nitrite. The gene discussed is PROS1; the disease is myeloid sarcoma.